Kezar Life Sciences, Inc.
NASDAQ:KZR
7.09 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -101.87 | -68.239 | -54.63 | -41.742 | -35.087 | -23.167 | -8.517 | -8.99 |
| Depreciation & Amortization
| 1.066 | 1.023 | 1.51 | 1.544 | 1.301 | 0.69 | 0.175 | 0.154 |
| Deferred Income Tax
| -6.347 | 0 | 1.77 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 18.137 | 14.006 | 7.596 | 4.943 | 4.007 | 1.993 | 0.203 | 0.128 |
| Change In Working Capital
| 4.706 | -4.459 | 1.226 | -2.011 | 0.881 | 0.062 | 0.03 | -1.052 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 6.347 | 1.814 | 1.217 | 0.313 | 2.208 | 1.44 | 0.081 | -0.469 |
| Other Working Capital
| -1.641 | -6.273 | 0.009 | -2.324 | -1.327 | -1.378 | -0.051 | -0.583 |
| Other Non Cash Items
| 2.663 | -1.177 | 0.091 | 0.317 | -0.979 | -0.37 | 0.472 | 0.979 |
| Operating Cash Flow
| -81.645 | -58.846 | -42.437 | -36.949 | -29.877 | -20.792 | -8.109 | -9.76 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -1.81 | -1.578 | -0.316 | -0.194 | -0.607 | -1.12 | -0.389 | -0.132 |
| Acquisitions Net
| 0.005 | 0.09 | 0.028 | 0.056 | -0.021 | 0.01 | 0 | 0 |
| Purchases Of Investments
| -180.399 | -332.203 | -156.378 | -225.728 | -102.255 | -119.244 | 0 | 0 |
| Sales Maturities Of Investments
| 258.25 | 242.389 | 128.25 | 169.424 | 123.281 | 36.45 | 0 | 0 |
| Other Investing Activites
| 77.856 | -0.09 | -0.028 | -0.056 | 0.021 | 0.01 | 0 | 0 |
| Investing Cash Flow
| 76.046 | -91.392 | -28.444 | -56.498 | 20.419 | -83.904 | -0.389 | -0.132 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | 0 | -9.531 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.638 | 127.861 | 103.054 | 99.642 | 0.272 | 77.695 | 49.755 | 0.036 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.638 | 127.861 | 19.062 | 99.642 | 0.272 | 0.218 | 49.755 | 0.036 |
| Financing Cash Flow
| 0.638 | 127.861 | 112.585 | 99.642 | 0.272 | 77.913 | 49.755 | 0.036 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -0.002 | -0.049 | -0.05 | 0.082 | -0.045 | -0.081 | 0.029 | -0.15 |
| Net Change In Cash
| -4.963 | -22.426 | 41.654 | 6.277 | -9.231 | -26.864 | 41.286 | -10.006 |
| Cash At End Of Period
| 35.493 | 40.456 | 62.882 | 21.228 | 14.951 | 24.182 | 51.046 | 9.76 |